allergan
Allergan’s revenue beats on higher U.S. brand sales
February 22, 2016 by creative · Leave a Comment
(Reuters) – Allergan Plc reported better-than-expected quarterly revenue, helped by strong performance in its U.S. brands segment, and said it continues to expect its takeover by Pfizer Inc to close in the second
Continued here:
Allergan’s revenue beats on higher U.S. brand sales
allergan
NY attorney general probing foreign exchange options market
November 24, 2015 by publisher · Leave a Comment
By David Ingram and John McCrank (Reuters) – New York Attorney General Eric Schneiderman's office is investigating the posting of false bids and offers in the foreign exchange options market for emerging market currencies, a
See more here:
NY attorney general probing foreign exchange options market
allergan
Icahn takes stake in Xerox, calls shares ‘undervalued’
November 24, 2015 by publisher · Leave a Comment
The billionaire revealed a 7.13 percent stake in Xerox in a securities filing on Monday, making him the second-largest shareholder of the 109-year-old company. Icahn, who recently took stakes in American International Group and Freeport-McMoran Inc , said he would look at getting representation on Xerox's board, as well as pursuing strategic alternatives. “We are aware that Carl Icahn has
Here is the original:
Icahn takes stake in Xerox, calls shares ‘undervalued’
allergan
Pfizer to buy Allergan in $160 billion deal
November 24, 2015 by creative · Leave a Comment
By Ransdell Pierson and Bill Berkrot NEW YORK (Reuters) – Pfizer Inc on Monday said it would buy Botox maker Allergan Plc in a deal worth $160 billion to slash its U.S. tax bill, rekindling a fierce political debate over the financial maneuver. The acquisition, which would create the world's largest drugmaker and shift Pfizer's headquarters to Ireland, would also be the biggest-ever instance of a U….
Originally posted here:
Pfizer to buy Allergan in $160 billion deal
allergan
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources
November 21, 2015 by elegant · Leave a Comment
Pfizer Inc and Allergan Inc chief executives have agreed on the roles they would assume in a combined company, removing one of the last hurdles to the largest ever healthcare merger, people familiar with the matter said. Pfizer CEO Ian Read will be CEO of the combined company, while Allergan CEO Brent Saunders will have another very senior role, the people said on Friday, without providing more details. Pfizer and Allergan declined to comment.
Original post:
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources